Clinical Trial Update: Efficacy and Safety of Glimepiride as Oral Anti-Diabetic (OAD) Initiation Mono-therapy in Chinese Type 2 Diabetes Mellitus (T2DM) [Phase 4]

View source ↗

Summary

This Phase 4 trial from Sanofi evaluates the efficacy and safety of initiating glimepiride as oral mono-therapy in Chinese patients with Type 2 diabetes mellitu…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Type 2 Diabetes Mellitus

Drugs mentioned

• Glimepiride (glimepiride)

Snippet

Sponsor: Sanofi | Conditions: Diabetes Mellitus, Type 2 | Phase 4 | Status: COMPLETED